Author

S. A. Richard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:clustering· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

T. H. Burgess· 2 shared A. Fries· 1 shared A. Ganesan· 1 shared A. L. Snow· 1 shared A. M. Malloy· 1 shared B. Agan· 1 shared B. Dorjbal· 1 shared B. K. Agan· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

T. H. Burgess

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Antigenic cartography using hamster sera identifies SARS-CoV-2 JN.1 evasion seen in human XBB.1.5 booster sera

W. WANG, G. L. Bhushan, S. Paz, C. B. Stauft, P. Selvaraj, E. Goguet, K. A. Bishop-Lilly, R. Subramanian, R. Vassell, S. Lusvarghi, Y. Cong, B. Agan, S. A. Richard, N. Epsi, A. Fries, , C. D. Weiss

The paper uses hamster sera to map antigenic differences among SARS-CoV-2 variants, showing JN.1 has significant antigenic divergence from XBB.1.5.

bioRxiv · Apr 5, 2024 · PreprintMicrobiology

Durability of SARS-CoV-2-specific T cell responses at 12-months post-infection

Z. Lu, E. D. Laing, J. Pena-Damata, K. Pohida, M. S. Tso, E. C. Samuels, N. J. Epsi, B. Dorjbal, C. Lake, S. A. Richard, R. C. Maves, D. A. Lindholm, J. Rozman, C. English, N. Huprikar, , A. M. Malloy

This study examines SARS-CoV-2-specific T cell responses 12-months post-infection, finding durable responses with higher frequencies in those with severe acute illness.

bioRxiv · Aug 11, 2021 · PreprintImmunology